l-Dopa in Parkinson's Disease
- 1 September 1969
- journal article
- research article
- Published by Taylor & Francis in Hospital Practice
- Vol. 4 (9), 35-41
- https://doi.org/10.1080/21548331.1969.11705744
Abstract
What common ground might be shared by parkinsonian patients and Chilean miners suffering from chronic manganese poisoning? An effort to explain their clinical resemblances in terms of similar biochemical abnormalities in the brain bore fruit eventually in the L-dopa treatment, which is proving effective in both diseases. Dr. Cotzias details the sequence of hypotheses explored along the way.Keywords
This publication has 8 references indexed in Scilit:
- Modification of Parkinsonism — Chronic Treatment with L-DopaNew England Journal of Medicine, 1969
- Functional Interactions between Biogenic Amines, 3′,5′-cyclic AMP and ManganeseNature, 1968
- Chronic manganese poisoning Clearance of tissue manganese concentrations with persistence of the neurological pictureNeurology, 1968
- Dopa and parkinsonism.BMJ, 1967
- Aromatic Amino Acids and Modification of ParkinsonismNew England Journal of Medicine, 1967
- Chronic manganese poisoningNeurology, 1967
- STRIATAL AMINES, EXPERIMENTAL TREMOR AND THE EFFECT OF HARMALINE IN THE MONKEYBrain, 1966
- Studies on the Metabolism and Mechanism of Action of MethyldopaCirculation, 1963